Skip to main content

LU Q42 Pill - blue & yellow capsule/oblong, 21mm

Pill with imprint LU Q42 is Blue & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Fenofibric acid is used in the treatment of High Cholesterol; Hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU Q42

Fenofibric acid delayed-release 135 mg LU Q42
Fenofibric acid delayed-release 135 mg LU Q42
Fenofibric acid delayed-release 135 mg LU Q42

Fenofibric Acid Delayed-Release

LU Q42
135 mg
Blue & Yellow
21.00 mm
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
Inactive Ingredients
silicon dioxide, dibutyl sebacate, ethylcellulose, FD&C Blue No. 1, ferric oxide yellow, ferrosoferric oxide, gelatin, hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, potassium hydroxide, povidone k90, propylene glycol, shellac, sodium lauryl sulfate, sodium stearyl fumarate, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.